Delivery Order SPE2DE21D7010-SPE2D626F20F7
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $5,204.05 on November 14, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is for the supply of LEVERAGE LFS spinal medical devices and related surgical instruments, with performance to be completed by December 5, 2025, at Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on November 28, 2025, with an ultimate completion date of January 5, 2026. This fixed-price delivery order with economic price adjustment mechanism is for MAXCESS spinal surgical products and related medical technologies. The award was issued under an open market competitive procurement with no set-aside designation, reflecting...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order (Contract No. 4570300073) valued at $2,009.60 by the Defense Logistics Agency Medical Supply Chain on December 12, 2025. The contract covers the delivery of MAXCESS spinal surgical products and related medical devices to support Department of Defense and Department of Veterans Affairs healthcare operations. Structured as a firm...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on November 26, 2025, for the MAXCESS spinal surgical product line. The contract, which is structured as a fixed-price agreement with economic price adjustment provisions, carries an ultimate completion date of January 5, 2026, and will be performed at Nuvasive's San Diego, California...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $9,642.60 by the Defense Logistics Agency Medical Supply Chain on December 11, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting successful competition in an open market procurement. The award is scheduled for completion by January 2, 2026, with...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $2,438.82 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, for ultimate completion by December 11, 2025. This delivery order, designated as contract M5, carries no set-aside restrictions and represents an open market procurement. The award funds the supply of...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on December 12, 2025, with an ultimate completion date of January 6, 2026. The contract is structured as a firm fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting the company's competitive standing in open market federal...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $1,956.60 delivery order (Contract No. 4570300075) by the Defense Logistics Agency Medical Supply Chain on December 12, 2025, for the supply of MAXCESS spinal surgical products. The contract utilizes a fixed-price pricing structure with economic price adjustment mechanisms and carries no set-aside designation, reflecting successful competition in open market procurement....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $21,266.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 10, 2025. This firm fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by December 31, 2025, and will be performed at Nuvasive's San Diego facility. The contract carries no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., has been awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency (DLA) Medical Supply Chain for the MAXCESS spinal surgical product. The contract, issued on December 12, 2025, with an ultimate completion date of January 6, 2026, employs a fixed-price structure with economic price adjustment provisions. This award carries no set-aside designation, reflecting...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F20F7Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,956.60 on December 12, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by January 6, 2026, and involves the supply of MAXCESS spinal surgical products and related medical devices to support federal healthcare operations. The award was issued without set-aside designation, reflecting Nuvasive's successful competition in open market procurements. Performance will be conducted at Nuvasive's San Diego, California facility (92121). This delivery order is issued against Nuvasive's established Indefinite Delivery/Indefinite Quantity contract vehicle—an $8 million Blanket Purchase Agreement with the Defense Health Agency effective through March 2027—which streamlines procurement of the company's comprehensive portfolio of spinal fusion devices, implants, surgical instruments, and bone graft materials for Department of Defense and Department of Veterans Affairs medical facilities. Nuvasive has demonstrated sustained capability as a critical supplier of specialized orthopedic and neurosurgical technologies to federal healthcare agencies, with delivery orders typically completed within weeks to months to meet the urgent medical supply needs of the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/11/25 |